Showing results (1-10 of 338) with videos related to
Sort By:
Pageof 34
Expert Opinion on Emerging Drugs|May 4, 2016
Emerging agents for the prevention of treatment induced neutropenia in adult cancer patientsAlexios Matikas, Vassilis Georgoulias, Athanasios KotsakisWorld Journal of Gastrointestinal Oncology|December 31, 2016
Role of circulating free DNA in colorectal cancerAlexios Matikas, Alexandra Voutsina, Maria Trypaki, et al.Expert Review of Anticancer Therapy|January 28, 2017
Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancerAlexios Matikas, Theodoros Foukakis, Ilias Michalakis, et al.Cancers|March 18, 2015
The place of targeted agents in the treatment of elderly patients with metastatic colorectal cancerAlexios Matikas, Natalia Asimakopoulou, Vassilis Georgoulias, et al.Clinical Lung Cancer|February 22, 2015
Current and Future Approaches in the Management of Non-Small-Cell Lung Cancer Patients With Resistance to EGFR TKIsAlexios Matikas, Dimitrios Mistriotis, Vassilis Georgoulias, et al.Clinical Lung Cancer|June 26, 2016
Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non-Small-cell Lung CancerAlexios Matikas, Nikolaos Kentepozidis, Vassilis Georgoulias, et al.Translational Lung Cancer Research|September 22, 2016
Targeting angiogenesis in small cell lung cancerMichalis Stratigos, Alexios Matikas, Alexandra Voutsina, et al.Breast Cancer Research : BCR|August 20, 2015
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patientsGalatea Kallergi, Sofia Agelaki, Maria A Papadaki, et al.Anticancer Research|September 10, 2014
Plasmablastic lymphoma of the breast in an immunocompetent patient: long-lasting complete response induced by chemotherapy and autologous stem cell trasplantationAlexios Matikas, George Kanellis, Christos Papadimitriou, et al.BMC Cancer|May 13, 2015
Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancerHara Polioudaki, Sofia Agelaki, Rena Chiotaki, et al.Pageof 34